The Equity-First Vaccination Initiative's Challenges And Successes

Published in: Health Affairs (2022). doi: 10.1377/forefront.20221101.246163

Posted on RAND.org on November 17, 2022

by Laura J. Faherty, Sarah Hanck, Nichelle Walton, George Timmins, Gregory Johnson, Jeanne S. Ringel

Read More

Access further information on this document at Health Affairs

This article was published outside of RAND. The full text of the article can be found at the link above.

RAND Corporation collected, analyzed, and co-interpreted with other Rockefeller Foundation Equity-First Vaccination Initiative (EVI) partners both quantitative and qualitative data throughout the initiative to promote equity in the COVID-19 response through vaccination. As detailed in RAND's final report on the EVI, there is clear evidence that the EVI reached its target population, with more than 90 percent of the nearly 65,000 vaccinations delivered through the EVI going to Black or Latinx individuals, or people identifying with two or more races.

Research conducted by

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.